|
<PAGE>
EXHIBIT 2.1
CONFIDENTIAL TREATMENT REQUESTED BY QLT INC.
ASSET PURCHASE AGREEMENT
AMONG
QLT USA, INC.,
AND
TOLMAR, INC.
AND
DILLFORD COMPANY S.A.
<PAGE>
TABLE OF CONTENTS
<TABLE>
<CAPTION>
PAGE
-----------------
<S> <C> <C>
ARTICLE I
DEFINITIONS..........................................................
1
Section 1.01
Definitions......................................................
1
ARTICLE II SALE AND PURCHASE OF
ASSETS.......................................... 12
Section 2.01 Sale and
Purchase................................................ 12
Section 2.02 Excluded
Assets.................................................. 13
Section 2.03 Assumed
Liabilities.............................................. 13
Section 2.04 Purchase
Price................................................... 14
Section 2.05 Adjustments to Purchase
Price.................................... 15
Section 2.06 Determination of
Adjustments..................................... 16
Section 2.07 Transfer Taxes;
Prorations....................................... 17
Section 2.08 Allocation of Purchase
Price..................................... 17
Section 2.09 Assignment and
Assumption........................................ 17
ARTICLE III THE
CLOSING..........................................................
18
Section 3.01 Time and Place of
Closing........................................ 18
Section 3.02 Deliveries by
Seller............................................. 18
Section 3.03 Deliveries by
Buyer.............................................. 20
Section 3.04 Deliveries by the
Parties........................................ 20
Section 3.05 Further
Assurances............................................... 20
ARTICLE IV REPRESENTATIONS AND WARRANTIES OF
SELLER............................. 21
Section 4.01 Organization and
Qualification................................... 21
Section 4.02
Authority........................................................
21
Section 4.03 No Conflicts; Required
Consents.................................. 22
Section 4.04 Financial
Statements............................................. 22
Section 4.05 Absence of
Changes............................................... 22
Section 4.06 Seller
Contracts................................................. 23
Section 4.07 Title; Sufficiency; Condition of
Assets.......................... 24
Section 4.08 Real
Property.................................................... 24
Section 4.09 Intellectual
Property............................................ 25
Section 4.10 Regulatory
Compliance............................................ 28
Section 4.11
Suppliers........................................................
29
</TABLE>
-i-
<PAGE>
TABLE OF CONTENTS
(continued)
<TABLE>
<CAPTION>
PAGE
-----------------
<S> <C> <C>
Section 4.12
Employees........................................................
30
Section 4.13 Employee Benefit
Plans........................................... 30
Section 4.14 Compliance with Legal Requirements; Governmental
Approvals....... 30
Section 4.15
Litigation.......................................................
31
Section 4.16 Environmental
Matters............................................ 31
Section 4.17
Taxes............................................................
32
Section 4.18
Brokers..........................................................
32
Section 4.19 Transactions with
Affiliates..................................... 32
Section 4.20
Solvency.........................................................
33
Section 4.21
Inventory........................................................
33
Section 4.22 Seller's Marketing
Efforts....................................... 33
ARTICLE V REPRESENTATIONS AND WARRANTIES OF
BUYER.............................. 34
Section 5.01 Organization and Good
Standing................................... 34
Section 5.02
Authority........................................................
34
Section 5.03 No Conflicts; Required
Consents.................................. 34
Section 5.04 Financial
Capacity............................................... 35
Section 5.05
Brokers..........................................................
35
Section 5.06
Debarment........................................................
35
Section 5.07 Title
Commitments................................................ 35
Section 5.08 Purchase in Good
Faith........................................... 35
ARTICLE VI ADDITIONAL
COVENANTS................................................. 36
Section 6.01 Transactions and Conduct of Business Pending the
Closing......... 36
Section 6.02 Employee
Matters................................................. 37
Section 6.03 401(k)
Plan...................................................... 38
Section 6.04 Access to
Information............................................ 39
Section 6.05 Notice of Certain
Events......................................... 39
ARTICLE VII ADDITIONAL
AGREEMENTS................................................ 40
Section 7.01
Confidentiality..................................................
40
Section 7.02 Use of
Proceeds.................................................. 41
</TABLE>
-ii-
<PAGE>
TABLE OF CONTENTS
(continued)
<TABLE>
<CAPTION>
PAGE
-----------------
<S> <C> <C>
Section 7.03 No Shop and
Non-Solicitation..................................... 41
Section 7.04
COBRA............................................................
41
ARTICLE VIII TERMINATION OF
AGREEMENT............................................. 42
Section 8.01 Grounds for
Termination.......................................... 42
Section 8.02 Effect of
Termination............................................ 42
ARTICLE IX
INDEMNIFICATION......................................................
42
Section 9.01 Survival of Representations and
Warranties....................... 42
Section 9.02 Indemnification by
Seller........................................ 42
Section 9.03 Indemnification by
Buyer......................................... 43
Section 9.04 Environmental
Indemnification.................................... 43
Section 9.05 Procedures for Indemnification; Buyer's Security
Interest in
Escrow
Amount.................................................... 44
Section 9.06 Limitations on
Indemnification................................... 46
Section 9.07 Damages
Limitations.............................................. 47
Section 9.08 Specific
Performance............................................. 47
Section 9.09 Exclusive
Remedy................................................. 47
Section 9.10 Characterization of Indemnification
Payment...................... 48
Section 9.11 No Other
Representation.......................................... 48
ARTICLE X
MISCELLANEOUS........................................................
48
Section 10.01 Amendments and
Waivers........................................... 48
Section 10.02
Notices..........................................................
48
Section 10.03 Applicable
Law................................................... 49
Section 10.04 Exhibits and
Schedules........................................... 50
Section 10.05 Assignments; Successors and
Assigns.............................. 50
Section 10.06 No Third-Party
Beneficiaries..................................... 50
Section 10.07
Counterparts.....................................................
50
Section 10.08
Severability.....................................................
50
Section 10.09 Entire
Agreement................................................. 50
Section 10.10
Interpretation...................................................
50
Section 10.11
Construction.....................................................
51
</TABLE>
-iii-
<PAGE>
TABLE OF CONTENTS
(continued)
<TABLE>
<CAPTION>
PAGE
-----------------
<S> <C> <C>
Section 10.12 Expenses of the
Parties.......................................... 51
Section 10.13 Jurisdiction; Service of
Process................................. 51
Section 10.14 Waiver of Jury
Trial............................................. 51
Section 10.15 Recovery of Fees by Prevailing
Party............................. 52
Section 10.16 Seller Disclosure
Schedule....................................... 52
Section 10.17 Time of the
Essence.............................................. 52
Exhibits
Form of Aczone(R) Manufacturing and Supply
Agreement............................. Exhibit A
Form of Assignment and Assumption
Agreement...................................... Exhibit B
Form of Atrigel(R) Manufacturing and Supply
Agreement............................ Exhibit C
Form of Eligard(R) Manufacturing and Supply
Agreement............................ Exhibit D
Form of Escrow
Agreement.........................................................
Exhibit E
Form of Governmental Approval
Assignments........................................ Exhibit F
Form of Guarantee
Agreement......................................................
Exhibit G
Form of Deed of Trust and Fixture
Filing......................................... Exhibit H
Form of Non-Competition
Agreement................................................ Exhibit
I
Form of Pledge
Agreement.........................................................
Exhibit J
Form of Promissory
Note..........................................................
Exhibit K
Form of Security
Agreement.......................................................
Exhibit L
Form of Transition Service
Agreement............................................. Exhibit
M
Form of Pre-Closing
Certificate..................................................
Exhibit 2.06(a)
Form of General Assignment and Bill of
Sale...................................... Exhibit 3.02(a)
Form of Patent
Assignment........................................................
Exhibit 3.02(b)-1
Form of Trademark
Assignment.....................................................
Exhibit 3.02(b)-2
Form of Special Warranty
Deed.................................................... Exhibit
3.02(c)
Form of FIRPTA
Affidavit.........................................................
Exhibit 3.02(h)
Form of
Opinion..................................................................
Exhibit 3.02(k)
Form of Press
Release............................................................
Exhibit 7.01(c)
Seller Disclosure Schedules
Dental
Products..................................................................
Schedule 2.01(b)
Deposits and
Advances............................................................
Schedule 2.01(c)
Generic Dermatology
Products.....................................................
Schedule 2.01(d)
Governmental
Approvals...........................................................
Schedule 2.01(e)
Transferred
Inventory............................................................
Schedule 2.01(g)
Owned and leased
Vehicles........................................................
Schedule 2.01(h)
Personal Property (including all Tools, Machinery and
Equipment)................. Schedule 2.01(i)
Personal Property
Leases.........................................................
Schedule 2.01(j)
</TABLE>
-iv-
<PAGE>
TABLE OF CONTENTS
(continued)
<TABLE>
<CAPTION>
PAGE
-----------------
<S> <C>
Real
Property....................................................................
Schedule 2.01(k)
Seller Contracts/Key
Contracts...................................................
Schedule 2.01(l)
Seller Intellectual
Property.....................................................
Schedule 2.01(m)
Excluded
Assets..................................................................
Schedule 2.02(e)
Excluded
Liabilities.............................................................
Schedule 2.03
Allocation of Purchase
Price..................................................... Schedule
2.08
Seller's Required
Consents.......................................................
Schedule 4.03
Pro Forma Income
Statement.......................................................
Schedule 4.04
Absence of
Changes...............................................................
Schedule 4.05
Additional Assets to be Purchased by
Buyer....................................... Schedule 4.07
Regulatory
Compliance............................................................
Schedule 4.10
Suppliers........................................................................
Schedule 4.11
List of Current
Employees........................................................
Schedule 4.12(a)
Employee Legal
Issues............................................................
Schedule 4.12(b)
Claims by
Employees..............................................................
Schedule 4.12(c)
Employee Benefit
Plans...........................................................
Schedule 4.13
Environmental
Matters............................................................
Schedule 4.16
Transactions with
Affiliates.....................................................
Schedule 4.19
Seller's Transactions and Conduct of
Business.................................... Schedule 6.01
List of Key
Employees............................................................
Schedule 6.02(a)
Employee Benefit Plans for Transferred
Employees................................. Schedule 6.02(c)
401(k) Plan Participation for Transferred
Employees.............................. Schedule 6.03(a)
</TABLE>
-v-
<PAGE>
ASSET PURCHASE AGREEMENT
THIS ASSET PURCHASE AGREEMENT is made as of December 20, 2006
(the
"Effective Date"), by and among Tolmar, Inc., a Delaware
corporation ("Buyer")
and a newly formed wholly-owned subsidiary of Dillford Company
S.A., a Uruguayan
sociedad anonima ("Parent"), Parent and QLT USA, Inc., a
Delaware corporation
("Seller"). Buyer, Parent and Seller are sometimes referred to
herein
individually as a "Party" and collectively as the "Parties."
RECITALS
WHEREAS, Seller is engaged in the business of, among other
things,
developing and manufacturing topical generic dermatology
products pursuant to
the Sandoz Agreement and dental products for distribution in the
United States,
Canada and certain other countries; and
WHEREAS, Seller owns and operates an approximately 60,000 square
foot
manufacturing facility located in Fort Collins, Colorado, at
which Seller
manufactures the topical generic dermatology products and dental
products, as
well as other pharmaceutical products; and
WHEREAS, Buyer desires to purchase from Seller, and Seller
desires to sell
to Buyer; substantially all of the assets, properties, rights
and claims related
to the topical generic dermatology business, the Dental Business
and the
Manufacturing Facility on the terms and conditions set forth
herein;
NOW, THEREFORE, in consideration of the foregoing recitals and
the mutual
representations, warranties, covenants and promises contained
herein, the
adequacy and sufficiency of which are hereby acknowledged, the
Parties hereto
agree as follows:
AGREEMENT
ARTICLE I
DEFINITIONS
Section 1.01 DEFINITIONS.
(a) The following terms shall have the following meanings for
the
purposes of this Agreement:
"Aczone(R) Manufacturing and Supply Agreement" means that
certain
manufacturing and supply agreement between Seller and Buyer in
the form attached
hereto as Exhibit A, which the Parties intend to be an entirely
independent,
separate and severable agreement from this Agreement.
"Affiliate" means, with respect to any specified Person, (a) any
other
Person that, directly or indirectly, owns or controls, is under
common ownership
or control with, or is owned or controlled by, such specified
Person, (b) any
other Person that is a director, officer or partner or
<PAGE>
is, directly or indirectly, the beneficial owner of ten percent
(10%) or more of
any class of equity securities of the specified Person or a
Person described in
clause (a) of this paragraph, or (c) another Person of which the
specified
Person is a director, officer or partner or is, directly or
indirectly, the
beneficial owner of ten percent (10%) or more of any class of
equity securities.
"Agreement" means this Asset Purchase Agreement (including the
Seller
Disclosure Schedule and all other schedules and exhibits
attached hereto), as
amended from time to time.
"Assignment and Assumption Agreement" means the assignment and
assumption
agreement covering all of the Assumed Liabilities in the form
attached hereto as
Exhibit B.
"Atrigel(R) Manufacturing and Supply Agreement" means that
certain
manufacturing and supply agreement between Seller and Buyer in
the form attached
hereto as Exhibit C, which the Parties intend to be an entirely
independent,
separate and severable agreement from this Agreement.
"Books and Records" means all books, files, papers,
agreements,
correspondence, databases, information systems, programs,
software, documents
and records relating to the Purchased Assets or the Assumed
Liabilities,
primarily used in the Business, on whatever medium; but
excluding batch records
and similar manufacturing records that Seller is required to
maintain under
applicable Legal Requirements and those relating to the Excluded
Assets.
"Business" means the Generic Dermatology Business, the Dental
Business and
the Manufacturing Business, but excluding the Excluded
Assets.
"Business Day" means any day other than (a) a Saturday or a
Sunday or (b) a
day on which commercial banks located in Denver, Colorado are
generally closed
for business.
"Closing" means the consummation of the Transaction.
"Code" means the United States Internal Revenue Code of 1986, as
amended.
"Consent" means any approval, consent, ratification, permission,
waiver or
authorization (including any Governmental Approval).
"Contract" means any agreement, contract, consensual obligation,
promise,
understanding, arrangement, commitment or undertaking of any
nature (whether
written or oral and whether express or implied).
"Conveyance Document" means any and all deeds, bills of sale,
assignments
and other good and sufficient instruments of transfer,
conveyance and assignment
to effect or evidence the sale, conveyance, assignment,
transfer, and delivery
of the Purchased Assets to Buyer and to vest in Buyer title to
the Purchased
Assets in accordance with the terms of this Agreement.
"Copyrights" means all registered and unregistered copyrights,
including
such rights in and to all works of authorship and all other
rights of a similar
nature corresponding thereto throughout the world, whether
published or
unpublished, including associated rights to prepare,
-2-
<PAGE>
reproduce, perform, make derivative works of, display and
distribute copyrighted
works and copies, compilations and derivative works thereof.
"Damages" means and includes any loss, damage, injury,
Liability, claim,
demand, settlement, judgment, award, fine, penalty, Tax, fee
(including all
reasonable legal fees, accounting fees, expert fees or advisory
fees), charge,
cost (including any cost of investigation) or expense of any
nature.
"Dental Business" means all of Seller's right, title, interest
and
obligations to develop, manufacture and sell the Dental
Products, together with
all Contracts and Governmental Approvals for or relating
primarily to such
Dental Products.
"Dental Products" means those products as listed on Schedule
2.01(b).
"Deposits and Advances" means performance and other bonds,
security and
other deposits, advance payments, prepaid credits and deferred
charges primarily
used in or primarily related to the Business, all of which are
listed on
Schedule 2.01(c).
"Earn-Out Event" means the receipt by Buyer of a firm purchase
order from
Seller or Seller's licensee or sublicensee to manufacture the
Aczone product in
a quantity equal to [**] or more of the sales forecasted (by
Seller or Seller's
licensee) for the twelve month period immediately following the
commercial
launch of the Aczone product in the United States of America,
pursuant to and in
accordance with the terms of the Aczone(R) Manufacturing and
Supply Agreement at
any time after the Effective Date and prior to [**].
"Eligard(R) Manufacturing and Supply Agreement" means that
certain
manufacturing and supply agreement between Seller and Buyer in
the form attached
hereto as Exhibit D, which the Parties intend to be an entirely
independent,
separate and severable agreement from this Agreement.
"Encumbrance" means any lien, pledge, hypothecation, charge,
mortgage,
security interest, encumbrance, trust, claim, preference, right
of possession,
lease, tenancy, license, encroachment, covenant, Order, option,
right of first
refusal, preemptive right, exception, reservation, limitation or
impairment.
"Entity" means any corporation (including any non-profit
corporation),
general partnership, limited partnership, limited liability
partnership, joint
venture, estate, trust or company (including any limited
liability company or
joint stock company).
"Environmental Laws" means all federal, state and local
statutes,
regulations, orders, and applicable rules of common law relating
to pollution or
protection of the environment, including, without limitation,
those relating to
Releases or threatened Releases of Hazardous Materials or
otherwise relating to
the presence, production, generation, manufacture, processing,
disposal,
distribution, labeling, testing, control, cleanup, use,
treatment, storage,
transport or handling of Hazardous Materials.
----------
** Confidential Treatment Requested.
-3-
<PAGE>
"Environmental Permits" means any permit, approval,
identification, number,
license and other authorization required under any applicable
Environmental
Laws.
"ERISA" means the Employee Retirement Income Security Act of
1974, as
amended.
"Escrow Agreement" means the escrow and security agreement
between Buyer,
Seller and the Escrow Agent in the form attached hereto as
Exhibit E.
"Excluded Transferred Inventory" means (a) all raw materials,
work in
process and finished goods related to the Excluded Assets,
wherever located and
whether held by Seller or third parties, which inventory shall
remain the
property of Seller, but, to the extent located at the
Manufacturing Facility,
shall remain located at the Manufacturing Facility for the
benefit of Seller as
more specifically described in the Manufacturing and Supply
Agreements, (b) all
inventory for Calcipotriene, and (c) all inventory for
Fluticasone with a Net
Book Value in excess of [**].
"GAAP" means United States generally accepted accounting
principles in
effect on the date on which they are to be applied pursuant to
this Agreement,
applied consistently throughout the relevant periods.
"Generic Dermatology Business" means all of Seller's right,
title, interest
and obligations to develop and manufacture the Generic
Dermatology Products
pursuant to, and as more specifically set forth in, the Sandoz
Agreement,
together with all Contracts and Governmental Approvals for or
relating primarily
to the Generic Dermatology Products.
"Generic Dermatology Products" means those products listed on
Schedule
2.01(d).
"Governmental Approval" means any: (a) permit, license,
certificate,
concession, approval, consent, ratification, permission,
clearance,
confirmation, exemption, waiver or authorization issued,
granted, given or
otherwise made available by or under the authority of any
Governmental Authority
or pursuant to any Legal Requirement; or (b) right under any
Contract with any
Governmental Authority.
"Governmental Approval Assignments" means those assignments
necessary to
transfer the Governmental Approvals in the form attached hereto
as Exhibit F.
"Governmental Authority" means the: (a) government of the United
States or
any state, commonwealth, territory, county, municipality,
district or other
jurisdiction of any nature; (b) federal, state, local, municipal
or other
government; (c) governmental or quasi governmental authority of
any nature
(including any governmental division, subdivision, department,
agency, bureau,
branch, office, commission, council, board, instrumentality,
officer, official,
representative, organization, unit, body or Entity and any court
or other
tribunal); or (d) individual, Entity or body exercising, or
entitled to
exercise, any executive, legislative, judicial, administrative,
regulatory,
police, military or taxing or arbitral authority or power of any
nature.
----------
** Confidential Treatment Requested.
-4-
<PAGE>
"Guarantee Agreement" means that certain guarantee agreement in
the form
attached hereto as Exhibit G between Parent and Seller under
which Parent shall
irrevocably and unconditionally guarantee Buyer's obligations
under the
Promissory Note and Security Agreement.
"Hazardous Materials" means all substances defined as Hazardous
Substances,
Pollutants or Contaminants in the National Oil and Hazardous
Substances
Pollution Contingency Plan, 40 C.F.R. Section 300.5, any
petroleum,
hydrocarbons, petroleum products and any components, fractions,
or derivatives
thereof, and any other substance, chemical, waste or material
that is otherwise
regulated under any Environmental Law, including any that were
used or generated
in the Manufacturing Business during the Pre-Closing Period.
"Independent Accounting Firm" means any big "four" accounting
firm that
does not currently represent a Party or another independent
accounting firm of
international reputation mutually acceptable to Buyer and
Seller.
"Intellectual Property Rights" means any or all rights in and
to
intellectual property and analogous intangible property rights,
including,
without limitation, (a) Patents, Trade Secrets, Copyrights, and
Trademarks, (b)
any rights similar, corresponding or equivalent to any of the
foregoing anywhere
in the world, and (c) all rights thereunder (including the right
to enforcement
for past infringements thereof), remedies related there to
(including remedies
relating to past infringements thereof), and rights to
protection of interests
therein under the laws of all jurisdictions.
"IRS" means the Internal Revenue Service.
"Key Contract" means those Seller Contracts designated as key
contracts on
Schedule 2.01(l).
"Knowledge" or a similar statement qualifying a statement by the
Seller's
knowledge means, when capitalized, actual knowledge of Michael
R. Duncan, David
R. Speights, Sean F. Moriarty, Joe Winslow, Judy Goldberg or
James Munro, after
reasonable investigation in the Ordinary Course of their
respective duties.
"Legal Requirement" means any federal, state, local, municipal
or other
law, statute, constitution, ordinance, code, Order, edict,
decree, proclamation,
treaty, convention, rule, regulation, permit, ruling, directive,
pronouncement,
requirement (licensing or otherwise), specification,
determination or decision
that is, has been enacted, adopted, passed, approved,
promulgated, made,
implemented or otherwise put into effect by or under the
authority of any
Governmental Authority.
"Liability" means any debt, obligation, duty or liability of any
nature,
including without limitation, a contingent debt or liability,
regardless of
whether such debt, obligation, duty or liability would be
required to be
disclosed on a balance sheet prepared in accordance with GAAP
and regardless of
whether such debt, obligation, duty or liability is immediately
due and payable.
-5-
<PAGE>
"Manufacturing and Supply Agreements" means the Eligard(R)
Manufacturing
and Supply Agreement, the Atrigel(R) Manufacturing and Supply
Agreement and the
Aczone(R) Manufacturing and Supply Agreement.
"Manufacturing Business" means Seller's manufacture of the
products
comprising the Generic Dermatology Business, the Dental Business
and other
pharmaceutical products at the Manufacturing Facility.
"Manufacturing Facility" means the manufacturing facility
located in Fort
Collins, Colorado comprised of approximately 60,000 sq. ft
situated on
approximately eight (8) acres of land owned by Seller.
"Material Adverse Effect" means any circumstance, change,
development or
event that has had, or is reasonably likely to have, a material
adverse effect
on the business, assets, condition (financial or otherwise),
operations or
results of operations of the Business taken as a whole, other
than with respect
to any matters which, directly or indirectly, relate to or
result from (a)
public or industry knowledge relating to the Transaction, (b)
changes in GAAP or
regulatory accounting requirements, (c) changes generally
adversely affecting
the United States economy or the generic pharmaceutical
industry, or (d) war,
acts of terrorism or the outbreak of hostilities.
"Mortgage" means that certain deed of trust and fixture filing
in the form
attached hereto as Exhibit H.
"Net Book Value" means the net book value of an asset calculated
in
accordance with GAAP.
"No Shop Period" means that period of time commencing on the
Effective Date
and ending on the Closing Date.
"Non-Competition Agreement" means that certain non-competition
agreement
between Seller and Buyer in the form attached hereto as Exhibit
I.
"Order" means any temporary, preliminary or permanent order,
judgment,
injunction, edict, decree, ruling, pronouncement, determination,
decision,
verdict, stipulation, subpoena, writ or award that is or has
been issued, made,
entered, rendered or otherwise put into effect by or under the
authority of any
Governmental Authority.
"Ordinary Course of Business" or "Ordinary Course" means
occurrences in the
ordinary course of the Business, consistent with past practices
(other than as a
result of a violation of Law or breach of contract).
"Owned and Leased Vehicles" means all vehicles owned by Seller
and all
rights in vehicle leases to which Seller is a party, in either
case that are
primarily used in the Business, all of which are listed on
Schedule 2.01(h).
"Patents" means all United States and foreign patents and
utility models
and applications therefor (including all reissues, divisions,
re-examinations,
renewals, extensions, provisionals, continuations and
continuations-in-part
thereof), and all equivalent or similar rights anywhere in
-6-
<PAGE>
the world in inventions and discoveries, including, without
limitation,
invention disclosures related to the Business or any Purchased
Assets or Assumed
Liabilities and generated in connection with the Business, all
as set forth on
Schedule 2.01(m).
"Permitted Encumbrance" means each of the following
Encumbrances: (a) liens
for taxes, assessments and governmental charges that are not due
and payable as
of the Closing Date or are being contested in good faith; (b)
pledges or
deposits made in the Ordinary Course of Business, for which an
adjustment is set
forth on Exhibit 2.06(a); (c) liens of mechanics, materialmen,
warehousemen or
other like liens securing obligations incurred in the Ordinary
Course of
Business that are not due and payable as of the Closing Date or
are being
contested in good faith; (d) similar liens and encumbrances
which are incurred
in the Ordinary Course of Business and which do not in the
aggregate materially
detract from the value of any Purchased Asset or materially
impair the use
thereof in the operation of the Business; (e) zoning laws and
ordinances and
similar Legal Requirements regulating the use or occupancy of
any parcel of Real
Property or the activities conducted thereon that are imposed by
any
Governmental Authority having jurisdiction over such Real
Property; (f) rights
reserved to any Governmental Authority to regulate the affected
property; and
(g) as to any parcel of Real Property, any easements,
rights-of-way, servitudes,
permits, restrictions and minor imperfections or irregularities
in title which
are reflected in the public records and which do not
individually or in the
aggregate interfere with the right or ability to own, use,
occupy or operate the
Real Property or to convey good, marketable and indefeasible
title to such Real
Property.
"Person" means any individual, Entity or Governmental
Authority.
"Personal Property" means personal property, office furnishings,
supplies,
tools, machinery, equipment and other tangible personal property
primarily used
in the Business and located at the Manufacturing Facility,
including the
Personal Property listed on Schedule 2.01(i).
"Personal Property Leases" means rights in leases of Personal
Property to
which Seller is a party or by which any of the Personal Property
is bound, all
of which are listed on Schedule 2.01(j).
"Pledge Agreement" means that stock pledge agreement between
Parent and
Seller in the form attached hereto as Exhibit J.
"Post-Closing Period" means any taxable period beginning after
the close of
business on the Closing Date or, in the case of any tax period
which includes
any time before and after the close of business on the Closing
Date, the portion
of such period beginning after the close of business on the
Closing Date.
"Pre-Closing Period" means any taxable period ending at or
before the close
of business on the Closing Date or, in the case of any taxable
period which
includes any time before and after the close of business on the
Closing Date,
the portion of such period at or before the close of business on
the Closing
Date.
"Proceeding" means any action, suit, litigation, arbitration,
proceeding
(including any civil, criminal, administrative, investigative or
appellate
proceeding), prosecution, contest, hearing, inquiry, inquest,
audit, examination
or investigation that is or has been commenced,
-7-
<PAGE>
brought, conducted or heard at law or in equity or before any
Governmental
Authority or any arbitrator or arbitration panel.
"Promissory Note" means that certain secured promissory note, in
the form
attached hereto as Exhibit K, in the aggregate principal amount
of Eight Million
Four Hundred Thousand Dollars ($8,400,000).
"QLT USA Products" means the products to be manufactured by
Buyer for
Seller under the Manufacturing and Supply Agreements, including
all know-how,
Patents, regulatory approvals and other assets related
thereto.
"Real Property" means that certain parcel of land located in
Fort Collins,
Colorado, in the County of Larimer, State of Colorado,
consisting of
approximately eight (8) acres as more particularly described on
Schedule
2.01(k), together with all easements and interests appurtenant
thereto
including, but not limited to, any streets or other public ways
adjacent to the
Real Property and any appurtenant development rights or water or
mineral rights.
"Real Property Improvements" means all improvements located on
the Real
Property, including the Manufacturing Facility.
"Real Property Lease" means rights in real estate leases
primarily used in
the Business to which Seller is a party.
"Receivables" means all accounts and notes receivable, checks
and
negotiable instruments payable to Seller arising out of or
relating to the
Business.
"Release" means any release, spill, emission, discharge,
leaking, pumping,
pouring, dumping, injection, deposit, disposal, dispersal,
leaching or migration
of Hazardous Materials.
"Representatives" means officers, directors, employees,
attorneys,
accountants, advisors and agents of a Party.
"Sandoz Agreement" means, collectively, that certain
Collaboration, License
and Supply Agreement between Seller, and Sandoz Inc. (formerly
know as Geneva
Pharmaceuticals, Inc.) dated August 28, 2000, as subsequently
amended by
Amendment No. 1 to Collaboration, License and Supply Agreement
dated July 17,
2003, as subsequently amended by Amendment No. 2 to
Collaboration, License and
Supply Agreement dated November 11, 2004, including QLT USA's
rights under that
certain Common Interest Agreement, dated June 27, 2006, between
QLT USA and
Sandoz Inc.
"Security Agreement" means that certain security agreement
between Buyer
and Seller in the form attached hereto as Exhibit L.
"Security Documents" means the Promissory Note, the Security
Agreement, the
Pledge Agreement, the Guarantee and the Mortgage.
"Seller Assigned Intellectual Property" means all Seller
Intellectual
Property owned by Seller and exclusively related to the
Business, the Purchased
Assets, or the Assumed Liabilities.
-8-
<PAGE>
"Seller Assigned Intellectual Property Contracts" means all
Seller
Intellectual Property Contracts under which Seller has acquired
or been granted,
or granted or conveyed, any license, permission or other right
to utilize any
Seller Intellectual Property exclusively related to the
Business, the Purchased
Assets, or the Assumed Liabilities.
"Seller Contracts" means collectively all Contracts and rights
under any
and all Contracts to which Seller is a party or is subject or by
which Seller is
bound solely in connection with the Business or to which the
Business is
subject, all of which are listed on Schedule 2.01(l).
"Seller Intellectual Property" means all Intellectual Property
Rights
necessary for the Business as presently conducted, including,
without
limitation, as applicable, the manufacture, use, sale and other
enjoyment of the
Seller Products and the use of the Purchased Assets as currently
utilized in the
Business, but excluding software licenses for generally
available software used
in the Business that either requires consent, license or payment
of a fee to
assign.
"Seller Intellectual Property Contract" means any Contract under
which
Seller has acquired or been granted, or is granted or conveyed,
any license,
permission or other right to utilize any Seller Intellectual
Property.
"Seller Licensed Intellectual Property" means all Seller
Intellectual
Property not exclusively related to the Business, the Purchased
Assets, or the
Assumed Liabilities.
"Seller Products" means the Generic Dermatology Products and the
Dental
Products.
"Tax" or "Taxes" means (a) any net income, alternative or add-on
minimum
tax, gross income, gross receipts, sales, use, ad valorem, value
added,
transfer, franchise, profits, license, withholding, payroll,
employment, excise,
severance, stamp, occupation, premium, property, environmental
or windfall
profit tax, custom, duty or other tax, governmental fee or other
like assessment
or charge of any kind whatsoever, together with any interest,
penalty,
addition-to-tax or additional amount imposed by any Governmental
Authority
(domestic or foreign) responsible for the imposition of any such
tax, (b) any
Liability of Seller for the payment of any amount of the type
described in
clause (a) above as a result of being a member of an affiliated,
consolidated,
combined or unitary group, and (c) any Liability of Seller for
the payment of
any amount as a result of being party to any tax sharing
agreement or with
respect to the payment of any amounts of the type described in
clauses (a) or
(b) above as a result of any express or implied obligation to
indemnify any
other Person.
"Tax Authority" means Governmental Authority responsible for
the
imposition, assessment or collection of any Tax.
"Tax Return" means any return, statement, declaration, notice,
certificate
or other document that is or has been filed with or submitted
to, or required to
be filed with or submitted to, any Governmental Authority in
connection with the
determination, assessment, collection or payment of any Tax or
in connection
with the administration, implementation or enforcement of or
compliance with any
Legal Requirement related to any Tax.
"Trade Secrets" means all trade secrets and other rights in
know-how and
confidential or proprietary information under applicable law
throughout the
world, including, without limitation
-9-
<PAGE>
(financial, business, processing, manufacturing or marketing
information, new
developments, inventions, processes, and ideas), and all other
proprietary
information, in all such cases, that provide Seller with
advantages over
competitors who do not know or use it, as well as any and all
documentation
thereof (including all related lists, papers, blueprints,
drawings or
descriptions or identities of compositions, formulae, diaries,
notebooks,
specifications, designs, methods of manufacture and methods of
processing,
software, technical information, and compilations) and all
associated claims and
rights related thereto (excluding, for the avoidance of doubt,
rights subject to
issued or published Patents, Copyrights in published works, and
Trademarks).
"Trademarks" means any and all registered and unregistered
trademarks,
service marks, and general intangibles of a similar nature
(including, without
limitation, all logos, trade names, corporate names, trade
dress, slogans, and
product names), as well as all Internet domain names and
addresses and
general-use e-mail addresses, and all goodwill associated
therewith throughout
the world.
"Transaction" or "Transactions" means, collectively, the
transactions
contemplated by this Agreement.
"Transaction Documents" means this Agreement, all Exhibits and
attachments
thereto, and all other agreements, certificates, instruments,
documents and
writings delivered by Parent, Buyer and/or Seller in connection
with the
Transaction.
"Transfer Taxes" means all federal, state, local or foreign
sales, use,
transfer, real property transfer, mortgage recording, stamp
duty, value-added or
similar Taxes that may be imposed in connection with the
transfer of Purchased
Assets or assumption of Assumed Liabilities, together with any
interest,
additions to Tax or penalties with respect thereto and any
interest in respect
of such additions to Tax or penalties.
"Transferred Inventory" means all inventory of Seller Products
and all raw
materials, work in process and finished goods primarily used in
the Business
(other than the Excluded Transferred Inventory), wherever
located and whether
held by Seller or third parties, all of which is listed on
Schedule 2.01(g)
(which Schedule 2.01(g) describes such Transferred Inventory in
reasonable
detail and includes the following information with respect to
each item of
Transferred Inventory: inventory date, book value, item number
and description,
type, unit of measure, unit cost, stock room location, total
quantity, total
cost, manufacturing date, and expiration date), but excluding
the Excluded
Transferred Inventory.
"Transition Services Agreement" means that certain transition
services
agreement between Buyer and Seller in the form attached hereto
as Exhibit M.
(b) Each of the following terms is defined in the section set
forth
opposite such term below:
<TABLE>
<S> <C>
Assumed Liabilities Section 2.03
Bankruptcy Code Section 5.07(e)
Biologic Section 4.10(a)
Burrill Section 4.18
Buyer Preamble
</TABLE>
-10-
<PAGE>
<TABLE>
<S> <C>
Buyer Damages Section 9.02
Buyer Defined Contribution Plan Section 6.03(a)
Buyer Welfare Benefit Plans Section 6.02(d)
Buyer's Basket Section 9.06(b)(i)
Buyer's Indemnification Cap Section 9.06(b)(ii)
Claim Notice Section 9.05(a)(i)(A)
Closing Date Section 3.01
COBRA Qualified Beneficiaries Section 7.04
Drug Section 4.10(a)
Effective Date Preamble
Employees Section 4.12(a)
Escrow Section 2.04(b)
Escrow Agent Section 2.04(b)
Escrow Amount Section 2.04(b)
Escrow Payment Section 2.04(b)
Escrow Percentage Section 2.04(b)
Excluded Assets Section 2.02
Excluded Liabilities Section 2.03
FDA Section 4.14
FDCA Section 4.14
General Assignment and Bill of Sale Section 3.02(a)
Indemnitee Section 9.05(a)(i)
Indemnitor Section 9.05(a)(i)
Initial Payment Section 2.04(a)(i)
Notice Period Section 9.05(a)(i)(B)
Parent Preamble
Parties Preamble
Party Preamble
Permits Section 4.14
Post-Closing Certificate Section 2.06(b)
Pre-Closing Certificate Section 2.06(a)
Pro Forma Income Statement Section 4.04
Purchase Price Section 2.04(a)
Purchased Assets Section 2.01
Required Consents Section 4.03
Restricted Asset Section 2.09(a)
Seller Preamble
Seller Damages Section 9.03
Seller Disclosure Schedule ARTICLE IV
Seller Plans Section 4.13
Seller Registered Intellectual Property Rights Section
4.09(a)
Seller's Basket Section 9.06(a)(i)
Seller's Indemnification Cap Section 9.06(a)(ii)
Survival Date Section 9.01
Third Party Acquisition Section 6.03
Title Commitments Section 5.07
</TABLE>
-11-
<PAGE>
<TABLE>
<S> <C>
Title Company Section 5.07
Title Policies Section 3.02(l)
Transferred Employee Section 6.02(a)
</TABLE>
ARTICLE II
SALE AND PURCHASE OF ASSETS
Section 2.01 SALE AND PURCHASE. Subject to the terms and
conditions set
forth in this Agreement, at the Closing, Seller shall sell,
transfer, convey,
assign and deliver to Buyer, and Buyer shall purchase from
Seller, all of
Seller's right, title and interest in the assets, properties,
goodwill and
rights of Seller primarily used in the Business, other than the
Excluded Assets
(collectively, the "Purchased Assets"), including the
following:
(a) the Books and Records;
(b) the Dental Products;
(c) the Deposits and Advances;
(d) the Generic Dermatology Products;
(e) the Governmental Approvals (and pending applications
therefor)
necessary to conduct the Business, all of which are listed on
Schedule
2.01(e);
(f) the Real Property Improvements;
(g) the Transferred Inventory;
(h) the Owned and Leased Vehicles;
(i) the Personal Property;
(j) the Personal Property Leases;
(k) the Real Property;
(l) the Seller Contracts and Seller Assigned Intellectual
Property
Contracts;
(m) the Seller Assigned Intellectual Property;
(n) all goodwill generated by or associated with the Business;
and
(o) all other assets, properties, rights and claims
(excluding
Intellectual Property Rights not otherwise included in
subsections (a)
through (n) above) primarily used in the Business, including,
without
limitation, all pending claims under any insurance policy of
Seller to the
extent such claims relate to damage to any Purchased Asset, to
any Assumed
Liability, or to the Business.
-12-
<PAGE>
Section 2.02 EXCLUDED ASSETS. Notwithstanding the provisions of
Section
2.01, the Purchased Assets shall not include the following
(collectively, the
"Excluded Assets"):
(a) cash, cash equivalents, marketable securities and
Receivables;
(b) any intercompany or intracompany receivable cash balances
between
Seller and any of its Affiliates or between any of its
Affiliates;
(c) corporate seals, certificates of incorporation, minute
books,
stock transfer records, or other records related to the
corporate
organization of Seller;
(d) the Seller Plans and contracts of insurance for employee
group
medical, dental and life insurance plans and all insurance
policies and
rights and claims thereunder;
(e) the assets listed on Schedule 2.02(e);
(f) subject to Section 2.01(o), all insurance policies and
rights and
claims thereunder;
(g) all personnel records (but at the Closing Seller shall
deliver to
Buyer copies of all such excluded records relating to the
Transferred
Employees, other than any employee medical or other records that
Seller is
prohibited from disclosing to Seller under applicable Legal
Requirements)
and other records, including batch records and similar
manufacturing
records that Seller is required to maintain in its possession
under
applicable Legal Requirements (but at the Closing Seller shall
deliver to
Buyer copies of all such batch records and similar manufacturing
records
relating to the Purchased Assets or the Assumed Liabilities,
primarily used
in the Business, other than any such records that Seller is
prohibited from
disclosing to Seller under applicable Legal Requirements);
(h) all rights of Seller under the Transaction Documents;
(i) the Excluded Transferred Inventory; and
(j) all assets, of whatever nature, not primarily used in
the
Business, including, without limitation, the QLT USA Products
and all
polymer manufacturing equipment, contracts to purchase raw
materials,
license, distribution and contract manufacturing agreements for
or related
to the QLT USA Products. For the avoidance of doubt, all assets
not
specifically set forth on the Schedules referenced in Section
2.01 of this
Agreement shall be deemed Excluded Assets.
Section 2.03 ASSUMED LIABILITIES. Subject to the terms and
conditions of
this Agreement, at the Closing, Seller shall assign, and Buyer
shall assume, the
Assumed Liabilities. For the purposes of this Agreement, the
"Assumed
Liabilities" shall mean only the following Liabilities of
Seller, and in any
event shall not include any Excluded Liabilities: (a) all
accrued Liabilities of
the Business for which Buyer receives a credit under Section
2.05, (b) those
obligations and Liabilities attributable to periods after
Closing under the
Seller Contracts and Governmental Approvals (and pending
applications therefor)
that are included in the Purchased
-13-
<PAGE>
Assets, (c) other obligations and Liabilities of Seller only to
the extent that
there shall be an adjustment in favor of Buyer with respect
thereto pursuant to
Section 2.05, (d) all obligations and liabilities arising out of
Buyer's
ownership of the Purchased Assets or operation of the Business
after Closing,
and (e) all Liabilities arising after the Closing attributable
to the
Transferred Employees. Except only for Assumed Liabilities,
Buyer does not
assume, and shall not have any responsibility for, any
liabilities or
obligations of Seller, including but not limited to Liabilities
or obligations
associated with Excluded Assets (collectively, the "Excluded
Liabilities").
Without limiting the generality of the foregoing, Buyer does not
assume, and
shall not have any responsibility for, any Liabilities or
obligations of Seller
arising from or relating to any of the Excluded Liabilities set
forth on
Schedule 2.03.
Section 2.04 PURCHASE PRICE.
(a) Subject to the terms of this Agreement, as full
consideration for
the sale, transfer, conveyance, assignment and delivery of the
Purchased
Assets and the execution and delivery of the Transaction
Documents by
Seller to Buyer, Buyer shall pay to Seller Twenty-Two Million
Dollars
($22,000,000), as such sum may be adjusted pursuant to the
provisions of
this Agreement (the "Purchase Price"). The Purchase Price, plus
or minus
prorations and other adjustments pursuant to this Agreement,
shall be paid
to Seller as follows:
(i) on the Effective Date, Buyer shall deposit with the
Escrow
Agent a sum equal to Twelve Million Six Hundred Thousand
Dollars
($12,600,000) (the "Initial Payment"), in immediately available
U.S.
funds. On the Closing Date the Initial Payment, less the
Escrow
Percentage (which shall be remain deposited with the Escrow
Agent as
described in Section 2.04(b)) shall be delivered to Seller
and
credited against the Purchase Price, and all interest accrued on
the
Initial Payment while deposited with the Escrow Agent shall
be
delivered to Buyer;
(ii) no later than February 28, 2007, Buyer shall pay to
Seller
Four Million Two Hundred Thousand Dollars ($4,200,000), less
the
Escrow Percentage (which shall be deposited with the Escrow
Agent as
described in Section 2.04(b)), by wire transfer of
immediately
available U.S. funds, provided that Buyer may elect to prepay
such
amount at any time, in whole or in part, without premium or
penalty;
(iii) no later than March 31, 2007, Buyer shall pay to
Seller
Four Million Two Hundred Thousand Dollars ($4,200,000), less
the
Escrow Percentage (which shall be deposited with the Escrow
Agent as
described in Section 2.04(b)), by wire transfer of
immediately
available U.S. funds, provided that Buyer may elect to prepay
such
amount at any time, in whole or in part, without premium or
penalty;
and
(iv) within ten (10) Business Days following the occurrence
of
the Earn-Out Event, Buyer shall pay to Seller One Million
Dollars
($1,000,000) by wire transfer of immediately available U.S.
funds;
provided, however, that if the
-14-
<PAGE>
Earn-Out Event does not occur, then Buyer shall have no
obligation to
make such payment to Seller and the Purchase Price shall be
reduced
accordingly.
(b) Without limiting the generality of Sections 2.04(a)(i)
through
(iii), as security for the indemnification obligations of Seller
under this
Agreement, concurrently with any payment made pursuant to
Sections
2.04(a)(i) through (iii) Buyer shall deliver by wire transfer
of
immediately available U.S. funds to SunTrust Bank, a Georgia
banking
corporation, as escrow agent (the "Escrow Agent"), and Escrow
Agent shall
retain, ten percent (10%) (the "Escrow Percentage") of each such
payment of
Purchase Price payable by Buyer under Sections 2.04(a)(i)
through (iii)
(each an "Escrow Payment"). The Escrow Payments shall be held in
escrow
(the "Escrow") in accordance with the terms of the Escrow
Agreement. For
the avoidance of doubt, at any time on or after the Closing Date
the
aggregate Escrow Payments (collectively, the "Escrow Amount")
held in
escrow shall not exceed ten percent (10%) of the aggregate
Purchase Price
that would have been paid to Seller, absent the Escrow
Payments.
(c) SECURITY FOR SUBSEQUENT PAYMENTS. As security for
Buyer's
obligations to make the payments set forth in Sections
2.04(a)(ii) through
(iii), at the Closing Buyer shall execute and deliver the
Promissory Note,
the Security Agreement, the Mortgage, the Pledge Agreement and
the
Guarantee Agreement. Upon Seller's receipt of the payment set
forth in
Section 2.04(a)(iii), Seller shall promptly (and in any event
within three
(3) Business Days) take all necessary and appropriate action to
cause the
Promissory Note, the Security Agreement, the Mortgage, the
Pledge Agreement
and the Guarantee Agreement to be terminated and any collateral
secured
thereby to be released. If Buyer provides Seller with at least
five (5)
Business Days notice before such payment is to be made, Seller
shall
cooperate with Buyer to provide that such terminations and
releases shall
occur substantially simultaneously with Seller's receipt of such
payment.
Section 2.05 ADJUSTMENTS TO PURCHASE PRICE. The Purchase Price
shall be
subject to adjustment as follows:
(a) The Purchase Price shall be adjusted on a pro rata basis as
of the
Closing Date for all prepaid expenses (to the extent such
prepayments may
accrue to Buyer's benefit), accrued expenses and Liabilities
(including but
not limited to real and personal property Taxes), and prepaid
income and
deposits, all as determined in accordance with Seller's past
accounting
treatment thereof, consistently applied, and to reflect the
principle that
all expenses and income attributable to the Business for the
Pre-Closing
Period are for the account of Seller, and all expenses and
income
attributable to the Business for the Post-Closing Period are for
the
account of Buyer.
(b) There shall be credited to the account of Seller and become
the
property of Buyer (but only to the extent that Buyer is entitled
to the
benefit or value thereof after Closing), deposits relating to
the Business
that are held by third parties as of the Closing Date for the
account of
Seller or as security for Seller's performance of its
obligations (other
than with respect to Excluded Assets and any other deposits the
full
benefit of which will not be available to Buyer following the
Closing),
including deposits on leases and deposits for utilities.
-15-
<PAGE>
(c) The Purchase Price shall be adjusted, upward or downward,
to
reflect the amount by which the Net Book Value of the
Transferred Inventory
delivered to Buyer on the Closing Date is greater or less than
[**].
(d) There shall be credited to the account of Buyer, [**] of
the
Transfer Taxes paid by Buyer on behalf of Seller in accordance
with Section
2.07(a).
Section 2.06 DETERMINATION OF ADJUSTMENTS. Preliminary and
final
adjustments to the Purchase Price shall be determined as
follows:
(a) On the Effective Date, Seller shall deliver to Buyer a
report
substantially in the form attached hereto as Exhibit 2.06(a)
(the
"Pre-Closing Certificate"), certified as to completeness and
accuracy by
Seller, showing in detail the preliminary determination of the
adjustments
referred to in Section 2.05, if any, calculated as of the
Closing Date, and
any documents substantiating the adjustments proposed in the
Pre-Closing
Certificate.
(b) Within thirty (30) days after Closing, Seller shall deliver
to
Buyer a report (the "Post-Closing Certificate"), certified by
Seller in the
same manner as the Pre-Closing Certificate, showing in detail
the final
determination of all adjustments which were not calculated as of
the
Closing Date and containing any corrections to the Pre-Closing
Certificate,
together with any documents substantiating the adjustments
proposed in the
Post-Closing Certificate. Buyer shall provide Seller with
reasonable access
to all records which Buyer has in its possession and which are
necessary
for Seller to prepare the Post-Closing Certificate.
(c) Within thirty (30) days after receipt of the
Post-Closing
Certificate, Buyer shall give Seller written notice of Buyer's
objections,
if any, to the Post-Closing Certificate. If Buyer makes any such
objection,
the Parties shall endeavor to resolve Buyer's objections within
thirty (30)
days after Seller's receipt thereof. If Buyer and Seller are
unable to
resolve such objections within such thirty (30)-day period,
Seller and
Buyer shall cause the Independent Accounting Firm to resolve any
remaining
disputed amounts within one hundred twenty (120) days after the
Closing
Date. The determination of the Independent Accounting Firm shall
be
conclusive and binding upon Seller and Buyer, and Seller and
Buyer shall
bear equally the fees and expenses payable to the Independent
Accounting
Firm in connection with such determination. Within (i) ninety
(90) days
after the Closing Date, if Buyer does not timely object to the
Post-Closing
Certificate, or if it does so but its objections are resolved
within the
thirty (30)-day period provided above, or (ii) otherwise, within
ten (10)
Business Days after Buyer's objections are resolved as provided
above;
Buyer shall pay to Seller, or Seller shall pay to Buyer, as
applicable, the
amount by which the Purchase Price as finally determined is more
or less,
respectively, than the amount of the Purchase Price as estimated
in the
Pre-Closing Certificate.
----------
** Confidential Treatment Requested.
-16-
<PAGE>
Section 2.07 TRANSFER TAXES; PRORATIONS.
(a) Notwithstanding any Legal Requirements to the contrary, each
of
Buyer and Seller shall be responsible for [**] of any and all
Transfer
Taxes when due, and Buyer shall, at its own expense, file all
necessary Tax
Returns and other documentation with respect to all such
Transfer Taxes.
Buyer shall pay the full amount of such Transfer Taxes and the
Purchase
Price shall be adjusted to reflect Buyer's payment of Seller's
portion of
such Transfer Tax.
(b) Seller shall be responsible for and shall pay any Taxes
arising or
resulting from or in connection with the conduct of the Business
or the
ownership of the Purchased Assets attributable to the
Pre-Closing Period.
Buyer shall be responsible for and shall pay any Taxes arising
or resulting
from or in connection with the conduct of the Business or the
ownership of
the Purchased Assets attributable to the Post-Closing
Period.
(c) All real property, personal property, ad valorem or other
similar
Taxes (not including income Taxes) levied with respect to the
Purchased
Assets or the Business for a taxable period which includes (but
does not
end on) the Closing Date shall be apportioned between Buyer and
Seller
based on the number of days included in such period through but
excluding
the Closing Date and the number of days included in such period
on and
after the Closing Date.
Section 2.08 ALLOCATION OF PURCHASE PRICE. The Parties agree to
allocate
the Purchase Price among the Purchased Assets as specified on
Schedule 2.08. The
allocation of the Purchase Price set forth on Schedule 2.08 is
intended to
comply with the requirements of Section 1060 of the Code. The
Parties agree
that:
(a) such allocation was determined in an arm's length
negotiation and
that none of the Parties shall take a position on any Tax Return
(including
IRS Form 8594), before any Tax Authority or in any Proceeding
that is in
any way inconsistent with such allocation without the written
consent of
the other Party or unless specifically required pursuant to a
determination
by an applicable Tax Authority;
(b) they shall cooperate with each other in connection with
the
preparation, execution and filing of all Tax Returns related to
such
allocation; and
(c) they shall promptly advise each other regarding the
existence of
any tax audit, controversy or litigation related to such
allocation.
Section 2.09 ASSIGNMENT AND ASSUMPTION.
(a) Notwithstanding anything herein to the contrary, if an
attempted
sale, assignment, transfer or delivery of any Purchased Asset
would be
ineffective without the Consent of any third party, or if such
an act would
violate the rights of any third party in such Purchased Asset or
otherwise
affect adversely the rights of Buyer in such Purchased Asset,
and the
applicable Consent has not been obtained on or prior to the
Closing Date,
----------
** Confidential Treatment Requested.
-17-
<PAGE>
this Agreement shall not constitute an actual or attempted
sale,
assignment, transfer or delivery of such Purchased Asset (each,
a
"Restricted Asset"). Unless and until any such Consent is
obtained, such
Restricted Asset shall not constitute a Purchased Asset and any
associated
Liability shall not constitute an Assumed Liability for any
purpose
hereunder except to the extent provided in Section 2.09(c).
(b) In any such case, Seller shall use commercially reasonable
efforts
to obtain, as soon as practicable, such Consent. Buyer shall
cooperate
reasonably with Seller in obtaining such Consents, provided,
that Buyer
shall not be required to pay any cash consideration therefor or
give or
allow to remain in effect any guaranty, letter of credit,
performance bond
or other financial assurance. As soon as such Consent is
obtained, Seller
shall sell, transfer, convey, assign and deliver to Buyer, for
no
additional consideration, all of Seller's right, title and
interest in such
Restricted Asset, and such Restricted Asset shall constitute a
Purchased
Asset and all associated Liabilities shall constitute Assumed
Liabilities
for all purposes hereunder.
(c) Until such Consent shall have been obtained, Seller shall at
its
expense effect an alternate arrangement, in the form of a
license,
sublease, operating agreement or other arrangement, in any case
reasonably
satisfactory to Buyer, which results in Buyer receiving all the
benefits
and bearing all the ordinary course costs, Liabilities and
other
obligations with respect to each Restricted Asset, from the
Closing Date
until such time as such Consent is obtained, that Buyer would
have received
and borne, respectively, if such Restricted Asset had
constituted a
Purchased Asset as of the Closing.
ARTICLE III
THE CLOSING
Section 3.01 TIME AND PLACE OF CLOSING. The Closing shall occur
at the
offices of Morrison & Foerster LLP, 370 Seventeenth Street,
Suite 5200, Denver,
Colorado 80202, at 10:00 a.m., local time, on December 22, 2006
or such other
date and time as is mutually agreed to by the Parties (the
"Closing Date").
Section 3.02 DELIVERIES BY SELLER. On the Effective Date, Seller
shall
deliver the following items (duly executed by Seller and
notarized as
appropriate) to the Escrow Agent for delivery to Buyer at the
Closing, all of
which shall be in form and substance reasonably acceptable to
Buyer:
(a) General Assignment and Bill of Sale covering all of the
applicable
Purchased Assets, substantially in the form attached hereto as
Exhibit
3.02(a) (the "General Assignment and Bill of Sale");
(b) any and all documents necessary to properly assign, and
to
properly record the assignment, to Buyer of all of Seller's
right, title
and interest in and to the Seller Assigned Intellectual Property
in the
United States in the forms attached hereto as Exhibit 3.02(b)-1
and
3.02(b)-2;
-18-
<PAGE>
(c) a special warranty deed conveying the Real Property free and
clear
of all Encumbrances other than the Permitted Encumbrances in the
form
attached hereto as Exhibit 3.02(c);
(d) the Governmental Approval Assignments;
(e) such other specific instruments of sale, transfer,
conveyance and
assignment as Buyer may request;
(f) assignments of all Personal Property Leases;
(g) vehicle titles and assignments sufficient to transfer title
to the
Owned and Leased Vehicles;
(h) an affidavit of Seller, under penalty of perjury, that
Seller is
not a "foreign person" (as defined in the Foreign Investment in
Real
Property Tax Act and applicable regulations) and that Buyer is
not required
to withhold any portion of the consideration payable under this
Agreement
under the provisions of such Act, in the form attached as
Exhibit 3.02(h);
(i) the Required Consents for the Key Contracts and such other
Seller
Contracts that have been obtained by Seller, duly executed by
the
applicable third party, in form and substance reasonably
satisfactory to
Buyer;
(j) with respect to any financing statements filed against any
of the
Purchased Assets, UCC-3 termination statements;
(k) an opinion, dated as of the Closing Date, from Morrison
& Foerster
LLP, Seller's legal counsel, substantially in the form attached
hereto as
Exhibit 3.02(k);
(l) the irrevocable written commitment of the Title Company to
deliver
to Buyer an ALTA 1992 standard form owner's policies of title
insurance,
insuring a fee or leasehold interest, as applicable, in each
parcel of the
Real Property, all premiums and charges for which shall have
been paid by
Seller (the "Title Policies"), the premiums for additional
endorsements or
extended coverage, to the extent requested by Buyer shall be
paid by Buyer;
(m) a certificate of Seller's Secretary certifying as to: (i)
the
certificate of incorporation and bylaws of Seller as in effect
as of the
Effective Date, (ii) resolutions of Seller's stockholders and
its board of
directors authorizing the execution, delivery and performance of
this
Agreement and of all other Transaction Documents, and (iii) the
incumbency
of Seller's officers executing this Agreement and all other
Transaction
Documents; and
(n) a certificate from the Secretary of State of Colorado and
Delaware
as to Seller's good standing.
-19-
<PAGE>
Section 3.03 DELIVERIES BY BUYER. On the Effective Date, Buyer
shall
deliver the following items (duly executed by Buyer and
notarized as
appropriate) to the Escrow Agent for delivery to Seller at the
Closing, all of
which shall be in a form and substance reasonably acceptable to
Seller:
(a) the Initial Payment;
(b) a certificate of Buyer's Secretary certifying as to, as
applicable: (i) the certificate of incorporation and bylaws of
Buyer as in
effect as of the Effective Date, (ii) resolutions of Buyer's and
Parent's
stockholders, if applicable, and board of directors authorizing
the
execution, delivery and performance of this Agreement and of all
other
Transaction Documents, and (iii) the incumbency of Buyer's and
Parent's
officers executing this Agreement and all other Transaction
Documents;
(c) the Non-Competition Agreement; and
(d) the Promissory Note and the Mortgage.
Section 3.04 DELIVERIES BY THE PARTIES. On the Effective Date,
Parent,
Buyer and Seller, as applicable, shall deliver the following
items (duly
executed by the applicable Party and notarized, as appropriate)
to the Escrow
Agent f
|